| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/28/2001 | WO2001045699A1 Use of parthenolide to inhibit cancer |
| 06/28/2001 | WO2001045698A1 Combination therapy for treating neurodegenerative disease |
| 06/28/2001 | WO2001045697A1 Skin external agents and drugs |
| 06/28/2001 | WO2001045696A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid in iron chelating therapy |
| 06/28/2001 | WO2001045695A2 Calcium formate for use as a phosphorus binder and a dietary supplement |
| 06/28/2001 | WO2001045694A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001045692A1 Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them |
| 06/28/2001 | WO2001045691A2 Method of treating gastrointestinal tract disease with purinergic receptor agonists |
| 06/28/2001 | WO2001045689A2 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 06/28/2001 | WO2001045688A2 Use od desloratadine for treating allergic and inflammatory conditions in pediatric patients |
| 06/28/2001 | WO2001045687A2 Use of bioactive metabolites of gepirone for the treatment of psychological disorders |
| 06/28/2001 | WO2001045686A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045685A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045684A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045683A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045682A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045681A2 Naphthoquinone derivatives as cd45 inhibitors |
| 06/28/2001 | WO2001045680A2 Cd45 inhibitors |
| 06/28/2001 | WO2001045679A2 Use of chemotherapeutic agents for topical treatment |
| 06/28/2001 | WO2001045678A2 Medicament, a method for its production and the use thereof |
| 06/28/2001 | WO2001045677A1 Process for producing nanometer particles by fluid bed spray-drying |
| 06/28/2001 | WO2001045676A2 Extended release oral dosage composition |
| 06/28/2001 | WO2001045674A1 Process for producing nanometer particles by fluid bed spray-drying |
| 06/28/2001 | WO2001045671A2 Suspension comprising oxcarbazepine |
| 06/28/2001 | WO2001045668A2 Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine |
| 06/28/2001 | WO2001045667A2 Water-soluble powders for oral solution and use thereof |
| 06/28/2001 | WO2001045666A1 Use of cationic compounds |
| 06/28/2001 | WO2001045664A2 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 06/28/2001 | WO2001045663A2 USE OF AROMATIC POLYCYCLIC COMPOUNDS AS ACTIVATORS OF PPARs-TYPE RECEPTORS IN A COSMETIC OR PHARMACEUTICAL COMPOSITION |
| 06/28/2001 | WO2001045661A2 Cosmetic and/or pharmaceutical preparations |
| 06/28/2001 | WO2001045650A2 Cosmetic use of the residues from wine production |
| 06/28/2001 | WO2001045645A1 Chitosan biopolymer for the topical delivery of active agents |
| 06/28/2001 | WO2001045642A2 Pulmonary delivery of ribavirin or levovirin™ for systemic and quasi-systemic treatment of disease |
| 06/28/2001 | WO2001045641A2 Inhibitors of thrombin induced platelet aggregation |
| 06/28/2001 | WO2001045640A2 Barrier-forming composition |
| 06/28/2001 | WO2001045637A2 Novel 4(piperazinyl (8-quinolinyl)metyl)benzamides |
| 06/28/2001 | WO2001045599A1 Tissue sensitizing compounds for females with methods and apparatus for the delivery of these compounds |
| 06/28/2001 | WO2001045585A1 Dental prosthesis with means for the release of active substances |
| 06/28/2001 | WO2001045548A2 Surgical needle with weeping tip and method of use |
| 06/28/2001 | WO2001045509A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
| 06/28/2001 | WO2001045484A2 An improved process for preparing simvastatin |
| 06/28/2001 | WO2001040442A8 Novel bacterial isolate and the preparation and use of its active metabolites |
| 06/28/2001 | WO2001037667A8 Combination of n-phenyl-n'-benzoyl urea derivative and nectin compounds for parasite control |
| 06/28/2001 | WO2001014402A8 Antisense modulation of focal adhesion kinase expression |
| 06/28/2001 | WO2001010834A3 Antibacterial agents |
| 06/28/2001 | WO2001009122A3 Serotonergic benzofurans |
| 06/28/2001 | WO2001005414A8 Algae protein polysaccharide extraction and use thereof |
| 06/28/2001 | WO2001002561A3 Mammalian calcium channels and related probes, cell lines and methods |
| 06/28/2001 | WO2001002407A3 Taxane derivatives and processes for the preparation thereof |
| 06/28/2001 | WO2001002380A8 Antipsychotic cyclic n-aralkyl amines |
| 06/28/2001 | WO2000078776A3 Thiophene a2a receptor agonists |
| 06/28/2001 | WO2000078765A3 CHROMENO[4,3,2-de]ISOQUINOLINES AS POTENT DOPAMINE RECEPTOR LIGANDS |
| 06/28/2001 | WO2000077010A3 Substituted heterocycle fused gamma-carbolines |
| 06/28/2001 | WO2000076956A3 Enantiomers of n-desmethyl venlafaxine |
| 06/28/2001 | WO2000076454A3 Therapeutic compositions for ophthalmic use and therapeutic compositions for brain central lesions |
| 06/28/2001 | WO2000075144A3 Peroxynitrite decomposition catalysts and methods of use thereof |
| 06/28/2001 | WO2000075142A3 Dna methyltransferase inhibitors |
| 06/28/2001 | WO2000072855A3 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 06/28/2001 | WO2000070047A3 Full-length molecules expressed in human tissues |
| 06/28/2001 | WO2000068247A3 Serine proteases |
| 06/28/2001 | WO2000068181A3 Process for preparing (1r,2s,4r) -(-)-2-[(2'- {n,n-dimethylamino} -ethoxy)] -2-[phenyl] -1,7,7-tri- [methyl] -bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof |
| 06/28/2001 | WO2000067773A3 Combinations of immunosupressive agents for the treatment or prevention of graft rejections |
| 06/28/2001 | WO2000067697A3 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells |
| 06/28/2001 | WO2000066708A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/28/2001 | WO2000066116A3 Stable solid pharmaceutical compositions containing enalapril maleate |
| 06/28/2001 | WO2000066104A3 Ace-2 inhibiting compounds and methods of use thereof |
| 06/28/2001 | WO2000061753A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/28/2001 | WO2000061180A3 Products and methods for treating ptp lar related diseases |
| 06/28/2001 | WO2000057865A3 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
| 06/28/2001 | WO2000055194A3 Tuberculosis antigens and methods of use therefor |
| 06/28/2001 | WO2000044774A3 Inhibition of stat3 signal transduction for human cancer therapy |
| 06/28/2001 | WO2000042987A8 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections |
| 06/28/2001 | WO2000040569A8 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 06/28/2001 | WO2000003981A8 Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes |
| 06/28/2001 | WO1999063937A9 Multivalent macrolide antibiotics |
| 06/28/2001 | WO1999046575A3 Peptides containing a cholesterol recognition sequence and their uses |
| 06/28/2001 | US20010005760 Naphthyloxy acetic acid derivatives and a pharmaceutical composition comprising them as an active ingredient |
| 06/28/2001 | US20010005757 Meiosis regulating compounds |
| 06/28/2001 | US20010005756 New 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them |
| 06/28/2001 | US20010005737 Comprising oligoesters; use such as in hand lotions; can be used without nonionic surfactants as emulsifier |
| 06/28/2001 | US20010005729 Absorption rate of a pharmaceutically active amine such as pseudoephedrine is improved when formulated with an acidic nonsteroidal antiinflammatory drug such as ibuprofen in a liquid medium; includes dosage for children |
| 06/28/2001 | US20010005728 By administering a controlled release of oxybutynin in given dosage |
| 06/28/2001 | US20010005727 Comprising an oxidizing agent, first and second polar compounds of dielectric constant greater than 40, such as dimethyl sulfoxide and dimethyl sulfone; for muscle, tendon, joint or ligament pain |
| 06/28/2001 | US20010005726 Includes an organic solvent, a surfactant, and an oil; high in vivo bioavailability |
| 06/28/2001 | US20010005725 Antiparasitic compounds such as 4-(2,2-dibromocyclopropyl)-1-(2,6-dichloro-4-trifluoromethylphenyl)-1,2,3 -triazole |
| 06/28/2001 | US20010005724 Method for promoting ovulation, parturition, and lactation in mammals |
| 06/28/2001 | US20010005723 Method of treating isolated systolic hypertension |
| 06/28/2001 | US20010005722 endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1h-indazole-3-carboxamide hydrochloride |
| 06/28/2001 | US20010005720 Method of treating chronic progressive vascular scarring diseases |
| 06/28/2001 | US20010005719 Compositions and methods for treatment of mitochondrial diseases |
| 06/28/2001 | US20010005717 Gene transfer complexes of a polyethyleneimine having a hydrophilic polymer such as polyoxyethylene glycol coupled thereto, and a nucleic acid; use in gene therapy |
| 06/28/2001 | US20010005716 Core of an acid labile medicant such as didanosine, a binder and a disintegrant, and a coating of a methacrylic acid copolymer and plasticizer which protects drug at low pH but releases drug at pH of 4.5 or higher, anti-adherent |
| 06/28/2001 | US20010005715 Comprising the condensation reaction product of an aldose such as glucose and a benzene containing one or more hydroxy, amino, carboxy, or sulfonyl groups; use such as iron, zinc or manganese complex fertilizers for plants |
| 06/28/2001 | US20010005714 Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
| 06/28/2001 | US20010005712 Parenterally administering Product R, a peptide-nucleic acid preparation, in combination with one or more antiviral agents useful for treating AIDS or HIV infections including HIV protease inhibitors and nucleosides |
| 06/28/2001 | US20010005579 Providing an amount of beta-alanine and L-histidine to blood or blood plasma effective to increase beta-alanylhistidine dipeptide synthesis in a tissue, exposing tissue to blood or plasma to increase accumulation of dipeptide in the tissue |
| 06/28/2001 | US20010005514 L-ascorbic acid and pectin composition |
| 06/28/2001 | US20010005513 With water insoluble starch carrier; allows dry storage and lower doses of active ingredient |
| 06/28/2001 | US20010005512 Controlled release formulation of divalproex sodium |
| 06/28/2001 | DE19964224A1 New calcium complex of oxa-diaza-phosphaundecane derivative MS-325, useful as stabilizer for diagnostic compositions containing gadolinium complex of MS-325 and as antidote for heavy metal poisoning |